Recipharm Annual Report 2006

More documents

Recommendations

Info

CONSOLIDATED INCOME STATEMENTS Note 1 Jan 2006 31 Dec 2006 1 Jan 2005 31 Dec 2005 Operating income, etc. Net sales 918,686,689 835,234,323 Other operating income 7,137,124, 3,930,183 925,823,813 839,164,506 Operating expenses Raw materials and consumables -285,892,766 -254,673,736 Other external expenses 2, 3 -199,275,853 -189,375,973 Personnel costs 4 -299,748,784 -291,940,840 Depreciation of tangible and amortisation of Intangible non-current assets 7,8,9,10,11 -44,909,787 -30,391,178 Loss on disposal of tangible and intangible fixed assets -563,758 - Other operating expenses 5 -5,919,619 -3,025,299 -836,310,567 -769,407,026 Operating profit/loss 89,513,246 69,757,480 Result from financial items Other interest income and similar profit/loss items 1,206,933 465,039 Interest expenses and similar profit/loss items -5,986,890 -4,530,600 -4,779,957 -4,065,561 Profit/loss after financial items 84,733,289 65,691,919 Tax on profit for the year 6 -13,491,248 -16,517,343 Net profit/loss for the year 71,242,041 49,174,576
CONSOLIDATED BALANCE SHEETS ASSETS Note 31 Dec 2006 31 Dec 2005 Fixed assets Intangible fixed assets Product rights 7 232,014,452 83,713,758 Other intangible fixed assets 8 5,593,633 7,872,950 237,608,085 91,586,708 Intangible fixed assets Land and buildings 9 1,379,605 1,435,200 Improvement expenses for other parties’ property 10 3,146,944 4,325,261 Machinery and equipment 11 56,923,146 65,311,608 Constructions in progress 12 2,791,254 2,403,136 64,240,949 73,475,205 Financial fixed assets Other investments held as fixed assets 154,710 92,980 Other long-term receivables 15 0 6,321,115 Deferred tax assets 16 893,696 2,065,002 1,048,406 8,479,097 Total fixed assets 302,897,440 173,541,010 Current assets Inventories Raw materials and consumables 69,854,144 64,269,289 Products in process 24,878,802 26,056,904 Finished products and goods for resale 74,087,756 67,475,079 168,820,702 157,801,272 Current receivables Accounts receivable - trade 137,883,843 98,996,957 Income taxes recoverable 66,732,950 24,527,345 Other receivables 6,424,656 29,361,753 Prepaid expenses and accrued income 17 16,212,027 13,308,522 227,253,476 166,194,577 Cash and bank balances 18 99,180,124 80,869,580 Total current assets 495,254,302 404,865,429 TOTAL ASSETS 798,151 742 578,406,439
Page 1 and 2: ANNUAL REPORT AND CONSOLIDATED ACCO
Page 3 and 4: the form of powders and granulates,
Page 5 and 6: Research and development Recip’s
Page 7: Investments Gross investments for t
Page 11 and 12: CONSOLIDATED CASH FLOW STATEMENTS 1
Page 13 and 14: PARENT COMPANY BALANCE SHEETS ASSET
Page 15 and 16: PARENT COMPANY CASH FLOW ANALYSES O
Page 17 and 18: Depreciation/amortisation principle
Page 19 and 20: Note 3 Fees and remuneration for au
Page 21 and 22: The Norwegian branch stands for SEK
Page 23 and 24: PARENT COMPANY 31 Dec 2006 31 Dec 2
Page 25 and 26: Acquisition value via transfer of a
Page 27 and 28: Closing accumulated acquisition cos
Page 29 and 30: Repayments of borrowings within 5 y
Page 31 and 32: Stockholm, 22 March 2007 Anders G C

Recipharm Annual Report 2006

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?